权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Genome-wide Investigation of cis-splicing between Adjacent Genes

相邻基因之间顺式剪接的全基因组研究

基本信息

批准号：
10457253
负责人：
HUI LI
金额：
$ 32.3万
依托单位：
UNIVERSITY OF VIRGINIA
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-03 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10457253
关键词：
3-Dimensional Alternative Splicing Animal Model Animals Binding Bioinformatics Biological Biological Markers Cell Culture Techniques Cells Chimera organism Chimeric Proteins Code DNA Methylation DNA Sequence Data Data Set Databases Development Dideoxy Chain Termination DNA Sequencing Disease Epigenetic Process Event Exons Gene Expression Genes Genetic Transcription Genome Genomics Genotype Guide RNA Hematology Human Human Genome Human Genome Project Intercistronic Region Introns Investigation Knowledge Libraries Luciferases Malignant Neoplasms Mass Spectrum Analysis Methods Modeling Morphologic artifacts Multiomic Data Names Noise Normal Cell Normal tissue morphology Nuclear Online Systems Ontology Pattern Peptides Phenotype Physiology Process Proteins Publishing RNA RNA Interference RNA Splicing RNA analysis RNase protection assay Renilla Luciferases Reporter Research Resources Reverse Transcriptase Polymerase Chain Reaction Reverse Transcription Sagittaria Sampling Side Site Solid Source Spliced Genes System Techniques Testing Therapeutic Tissues Trans-Splicing Transcript Transcriptional Regulation Variant Western Blotting Work base cleavage factor epigenomics gene product genome-wide genome-wide analysis high throughput screening histone modification in vivo loss of function mouse model nano-string screening small hairpin RNA termination factor therapeutic target transcription factor transcriptome transcriptome sequencing web page web site

项目摘要

PROJECT SUMMARY Genes and their products (RNA and protein) are not expected to intermingle, except in the situation of cancer. However, this traditional dogma is being challenged when more and more chimeric RNAs being identified in non-cancer samples. Our work on trans-splicing and cis-splicing between adjacent genes (cis-SAGe) have provided evidence that the intergenic splicings may be another mechanism to expand functional genome. In this proposal, we are focusing on the genome-wide study of the transcriptional read-through fusions (we named them cis-SAGe to differentiate from other mechanisms). Traditionally, they were believed to be rare, or artifacts. Even when proven true, they were thought to be transcriptional noise or side products. However, in our preliminary studies, we have identified thousands of such fusion RNAs in non-cancer tissues and cells. Some have been validated, and proven functional. We hypothesize that cis-SAGe chimeric fusion RNAs are a widely spread phenomenon in normal physiology, and represent a means to diversify our transcriptome. To test this hypothesis, and to gain knowledge about these fusions at the genome level, we propose the following four aims: In Aim1, we will characterize the fusion RNAs and parental genes including junction sequence, protein-coding potential, expression, and gene ontology. The fusion RNAs will also be analyzed at multiple levels with multiple techniques including non RT-based Nanostring platform, and high throughput mass spectrometry. In Aim2, we will investigate the biological significance of the cis-SAGe fusions. A high throughput screening will be used followed by candidate approaches with both gain- and loss-of-function systems. For the loss-of-function system, we will use RNAi method, which is more mature in our hands. In addition, we will use our newly adapted dCAS9-KRAB method to achieve fusion-specific silencing. We will apply the perturbation in both cell culture and animal systems. One of the fusions will be examined in more detail in a “retrogenic” mice model. In Aim3, we will investigate the generating mechanisms of cis-SAGe with two approaches, a bioinformatics approach and a reporter approach. Bioinformatically, we will interrogate multi-omics data from ENCODE and Roadmap Epigenomics to investigate epigenetic signatures, transcriptional regulatory patterns, DNA methylation as well as the three-dimensional proximity of the cis-SAGe fusion sites. In the reporter system, we have built a two-part renilla luciferase separated by introns, exons and termination site of a model fusion RNA, and we are using the system to screen candidate factors. In Aim4, we will develop an interactive web-based database to allow end users to search for fusion RNAs in normal tissues and cells. The findings from the proposed study will have the potential of not only challenging traditional dogmas that chimeric RNAs are cancer-specific features, but also enhancing our understanding of the human genome and transcriptome. The chimeric RNAs may be misregulated in disease situations, thus expanding the repertoire for biomarker and therapeutic target discovery.

项目总结